Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,104,903
+$59,918 QoQ
Shares Held
8,288
-0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.85%
of 13F equity value
Holder Rank
#2,303
of 4,664 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PACES FERRY WEALTH ADVISORS, LLC holds $4,545,179 across 7 Drug Manufacturers - General names. JNJ ranks #1 (46.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
8,288 | $2,104,903 | |
| 2 | LLY |
ELI LILLY & Co
|
443 | $531,347 | |
| 3 | ABBV |
AbbVie Inc.
|
2,018 | $507,809 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,748 | $481,618 | |
| 5 | NVS |
Novartis AG
|
2,881 | $451,510 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,345 | $250,358 | |
| 7 | AMGN |
Amgen Inc
|
601 | $217,634 |
All Filings in JNJ
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,104,903 | 8,288 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,044,985 | 8,366 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,759,695 | 8,503 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,482,247 | 7,994 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,217,112 | 7,968 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,341,479 | 8,089 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,080,311 | 7,470 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,276,546 | 7,877 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,181,995 | 8,087 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,254,446 | 7,930 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,265,362 | 8,073 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $1,298,955 | 8,340 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,429,430 | 8,636 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,372,525 | 8,855 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $1,541,624 | 8,727 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,425,152 | 8,724 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $1,537,591 | 8,662 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,538,356 | 8,680 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $1,462,648 | 8,550 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $1,451,723 | 8,989 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $1,524,009 | 9,251 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,527,797 | 9,296 | Shares | Sole | 2021-05-19 | |
| 2020-12-31 | $1,430,112 | 9,087 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $1,325,627 | 8,904 | Shares | Sole | 2020-11-19 | |
| No filing history on record for this holder in this stock. | ||||||